Litigation Details for United HealthCare Services, Inc. v. Celgene Corporation DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT. (D. Minnesota 2020)

United HealthCare Services, Inc. v. Celgene Corporation DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT. (D. Minnesota 2020)

Docket		Date Filed	2020-03-05
Court	District Court, D. Minnesota	Date Terminated	2020-12-02
Cause	15:2 Antitrust Litigation	Assigned To	David Singleton Doty
Jury Demand	Plaintiff	Referred To	Elizabeth Cowan Wright
Patents	6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,119,106; 7,189,740; 7,230,012; 7,468,363; 7,959,566; 7,968,569; 8,204,763; 8,288,415; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,741,929; 9,056,120; 9,101,621; 9,101,622
Link to Docket	External link to docket

Biologic Drugs cited in United HealthCare Services, Inc. v. Celgene Corporation DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT.

Details for United HealthCare Services, Inc. v. Celgene Corporation DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT. (D. Minnesota 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-03-05	1		to a patient while Thalomid ‘501 Patent 6,045,501 28-Aug- 4-Apr-00 28-Aug- preventing…800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent.89 …800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent.90 …‘501 patent, the ‘976 patent, the ‘432 patent, the ‘984 patent, the ‘763 patent, the ‘188 patent, the…‘720 patent, the ‘977 patent, the ‘784 patent, the ‘399 patent, the ‘018 patent, the ‘566 patent, the	External link to document